文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

去甲肾上腺素联合血管加压素治疗脓毒性休克:来自中低收入国家的回顾性队列研究

Vasopressin in Conjunction With Norepinephrine in Septic Shock: A Retrospective Cohort Study From a Low Middle-Income Country.
PubMed 文献 · Crit Care Explor · 2020-11-09
一句话结论在巴基斯坦脓毒性休克患者中,去甲肾上腺素联合血管加压素与单用去甲肾上腺素相比住院死亡率无显著差异(校正OR 0.633,95%CI 0.370-1.081),但联合组患者基线更重、升压药使用时间和ICU入住时间更长。

该回顾性队列研究纳入巴基斯坦卡拉奇Aga Khan大学医院2019年1月至12月诊断的653例脓毒性休克患者,其中498例单用去甲肾上腺素,155例使用去甲肾上腺素-血管加压素联合。主要终点为住院死亡率,多因素logistic回归校正后联合用药与死亡率无显著关联(校正OR 0.633,95%CI 0.370-1.081)。入院SOFA评分(1.100 [1.014-1.193])、入院乳酸(1.167 [1.109-1.227])、升压药使用时长(1.481 [1.316-1.666])和护理级别(3.025 [1.682-5.441])与联合用药独立相关,提示医生对病情更重的难治性脓毒性休克患者使用了联合方案。联合组升压药使用时间和ICU入住时间也显著更高。

要点

  • 在653例脓毒性休克患者中,去甲肾上腺素-血管加压素联合组与单用去甲肾上腺素组住院死亡率无显著差异(校正OR 0.633,95%CI 0.370-1.081)。
  • 联合组入院SOFA评分和入院乳酸水平显著更高,提示医生对病情更重的难治性脓毒性休克患者使用了联合方案。
  • 入院SOFA评分(OR 1.100 [95%CI 1.014-1.193])、入院乳酸(OR 1.167 [1.109-1.227])、升压药使用时长(OR 1.481 [1.316-1.666])和护理级别(OR 3.025 [1.682-5.441])与联合用药独立相关。
  • 联合组升压药使用时间和ICU入住时间显著高于单用去甲肾上腺素组。
  • 作者指出,考虑到近期升压药价格飞涨且巴基斯坦多数医疗支出为自费,联合用药可能给患者及家庭带来不必要的经济负担。

适用人群与场景

  • 2019年1月至12月在巴基斯坦卡拉奇Aga Khan大学医院诊断为脓毒性休克的653例患者,其中498例单用去甲肾上腺素,155例使用去甲肾上腺素-血管加压素联合。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入653例脓毒性休克患者,比较去甲肾上腺素联合血管加压素(155例)与单用去甲肾上腺素(498例)的结局。
  • 主要终点住院死亡率:多因素logistic回归校正后,联合用药与死亡率无显著关联(校正OR 0.633,95%CI 0.370-1.081)。
  • 与联合用药独立相关的因素:入院SOFA评分(OR 1.100,95%CI 1.014-1.193)、入院乳酸(OR 1.167,95%CI 1.109-1.227)、升压药使用时长(OR 1.481,95%CI 1.316-1.666)、护理级别(OR 3.025,95%CI 1.682-5.441)。
  • 联合组升压药使用时间和ICU入住时间显著高于单用去甲肾上腺素组。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,巴基斯坦医生对病情更重的难治性脓毒性休克患者使用了去甲肾上腺素-血管加压素联合方案。
  • 作者指出,考虑到近期升压药价格飞涨且巴基斯坦多数医疗支出为自费,联合用药可能给患者及家庭带来不必要的经济负担。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Guidelines recommend use of norepinephrine as the first-line treatment for fluid-refractory septic shock and if septic shock persists vasopressin may be initiated. Since there are limited data from low middle-income countries with high disease burden of sepsis, we aimed to compare the outcomes of using vasopressin adjunct to norepinephrine in comparison with norepinephrine alone.

DESIGN: Retrospective cohort study.

SETTING: Aga Khan University Hospital, Karachi, Pakistan.

PATIENTS: Six-hundred fifty-three patients diagnosed with septic shock from January 2019 to December 2019, with 498 given norepinephrine only and 155 given norepinephrine-vasopressin combination.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Primary outcome was in-hospital mortality. Secondary outcomes were duration of vasopressor used, length of hospital stay, length of ICU stay, and days on ventilatory support. After adjustment by multivariable logistic regression, it was found that mortality was not significantly associated with the norepinephrine-vasopressin combination (adjusted odds ratio, 0.633 [95% CI, 0.370-1.081]). However, Sequential Organ Failure Assessment score at admission (1.100 [1.014-1.193]), lactate at admission (1.167 [1.109-1.227]), duration of vasopressor used (1.481 [1.316-1.666]), and level of care (3.025 [1.682-5.441]) were found to be independently associated with the adjunct usage of norepinephrine and vasopressin.

CONCLUSIONS: The use of norepinephrine-vasopressin combination has remained debatable in literature. Our study showed that although there was no difference in mortality between the two groups, admission Sequential Organ Failure Assessment scores and admission lactate levels were found to be significantly higher in the norepinephrine-vasopressin group. Hence, physicians from Pakistan used the norepinephrine-vasopressin combination in resistant septic shock patients who were sicker to begin with. Furthermore, duration of vasopressor therapy and ICU admission were also significantly higher in the combination group. Considering the recent hyperinflation of vasopressors costs and that most healthcare expenditure for patients in Pakistan is out-of-pocket, this can consequently lead to unwarranted financial burden for patients and their families.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Raza HA, Arshad A, Ayaz A, et al. Vasopressin in Conjunction With Norepinephrine in Septic Shock: A Retrospective Cohort Study From a Low Middle-Income Country. Crit Care Explor. 2020. PMID: 33196051. doi:10.1097/CCE.0000000000000274

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。